Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of Teclistamab for Patients with Previously Treated AL Amyloidosis

    Recruiting

    1 1
    Investigated drugs:
    France Germany Greece Italy The Netherlands
  • Study on the Safety and Effectiveness of Linvoseltamab, Sarilumab, and Dexamethasone in Adults with Relapsed or Refractory AL Amyloidosis

    Recruiting

    1 1 1
    Greece Spain
  • Study on Safe Skin Test Concentrations for Biotherapy Allergies in Patients with Cancer Using Atezolizumab, Daratumumab, and Nivolumab

    Not yet recruiting

    1 1 1 1
    France
  • Study on the Safety and Effectiveness of Sargramostim with Daratumumab, Cyclophosphamide, Bortezomib, and Dexamethasone in Untreated Light Chain Amyloidosis Patients

    Not recruiting

    1 1 1
    Poland
  • Study on the Effectiveness and Safety of CAEL-101 with Drug Combination for Patients with Advanced AL Amyloidosis

    Not recruiting

    1 1 1
    Investigated diseases:
    Austria Belgium Czechia France Germany Greece +3
  • Study on the Effectiveness and Safety of CAEL-101 with Plasma Cell Dyscrasia Treatment in Patients with Stage IIIa AL Amyloidosis

    Not recruiting

    1 1 1
    Investigated diseases:
    Austria Czechia France Germany Greece Italy +2
  • Study on Daratumumab, Cyclophosphamide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Systemic AL Amyloidosis

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Belgium Denmark France Germany Greece Hungary +5
  • Study of Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone for Patients with Newly Diagnosed AL Amyloidosis with Heart Involvement

    Not recruiting

    1 1 1
    France Germany Greece Italy The Netherlands Spain
  • Study on Birtamimab and Bortezomib for Patients with Advanced Light Chain Amyloidosis

    Not recruiting

    1 1 1
    Investigated diseases:
    Austria Belgium Czechia Denmark France Germany +8